[1. Huang D, Swanson EA, Lin CP, et al. Optical coherent tomography. Science. 1991;254:1178-1181.10.1126/science.195716946381691957169]Search in Google Scholar
[2. Prati F, Regar E, Mintz GS, et al. Imaging of atherosclerosis: optical coherence tomography (OCT). Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010; 31:401-415.10.1093/eurheartj/ehp43319892716]Search in Google Scholar
[3. Špaček R, Červinka P. Nové možnosti zobrazení koronárních tepen - optická koherentní tomografie. Cor Vasa. 2009;Supplementum 1:43-46.10.33678/cor.2009.221]Search in Google Scholar
[4. Regar E, Ligthart J, Bruining N, van Soest G. The diagnostic value of intracoronary optical coherence tomography. Herz. 2011;36:417-429.10.1007/s00059-011-3487-721744151]Search in Google Scholar
[5. Hong MK, Mintz GS, Lee CW et al. Late stent malaposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414-419.10.1161/CIRCULATIONAHA.105.56340316432073]Search in Google Scholar
[6. Tanigawa J, Barlis P, Kaplan S, Goktekin OCD. Stent strup apposition in complex lesions using optical coherence tomography. Am J Cardiol. 2006;98(Suppl 1):97M.]Search in Google Scholar
[7. Radu M, Jørgensen E, Kelbæk H, Helqvist S, Skovgaard L, Saunamäki K. Optical coherence tomography at followup after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention. 2011;7:353-361.10.4244/EIJV7I3A6021729838]Search in Google Scholar
[8. Reimers B, Nikas D, Stabile E, Favero L, Saccà S, Cremonesi A, Rubino P. Preliminary experience with optical coherence tomography imaging to evaluate carotid artery stents: safety, feasibility and techniques. EuroIntervention. 2011;7:98-105.10.4244/EIJV7I1A1721550909]Search in Google Scholar
[9. Liu Y, Imanishi T, Kubo T, et al. Assessment by optical coherence tomography of stent struts across side branch. Comparison of bare-metal stents and drug-elution stents. Circ J. 2010;75:106-112.10.1253/circj.CJ-10-0574]Search in Google Scholar
[10. Murata A, Wallace-Bradley D, Tellez A, et al. Accuracy of optical coherent tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010;3:76-84.10.1016/j.jcmg.2009.09.01820129535]Search in Google Scholar
[11. Suzuki Y, Ikeno F, Koizumi T, et al. In vivo comparison between optical coherent tomography and intravascular ultrasound for detecting small degrese of in-stent neointima after stent implantation. JACC Cardiovasc Interv. 2008;1:168-173.10.1016/j.jcin.2007.12.00719463295]Search in Google Scholar
[12. Capodanno D, Prati F, Pawlowsky T, Cera M, La Manna A, Albertucci M, Tamburino C. Comparison of optical coherence tomography and intravascular ultrasound for the assessment of in-stent tissue coverage after stent implantation. EuroIntervention. 2009;5:538-543.10.4244/EIJV5I5A8820142173]Search in Google Scholar
[13. www.medis.nl]Search in Google Scholar
[14. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelization. Circulation. 2007;115:2435-2441.10.1161/CIRCULATIONAHA.107.69373917438147]Search in Google Scholar
[15. Li S, Wang Y, Gai L, et al. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography. Int J Cardiol. 2011;doi:10.1016/j.ijcard.2011.05.076.10.1016/j.ijcard.2011.05.07621641053]Search in Google Scholar
[16. Fujii K, Kawasaki D, Oka K, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation.]Search in Google Scholar
[Heart. 2011;97:977-82.10.1136/hrt.2010.20459421193688]Search in Google Scholar
[17. Inoue T, Shite J, Yoon J, et al. Optical coherence evaluation of everolimus-eluting stents 8 months after implantation. Heart. 2011;97:1379-1384.10.1136/hrt.2010.20433921051456]Search in Google Scholar
[18. Guagliumi G, Sirbu V, Musumeci G, et al. Strut coverage and vessel wall response to a new-generation paclitaxeleluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv. 2010;3:367-375.10.1161/CIRCINTERVENTIONS.110.95015420647562]Search in Google Scholar
[19. La Manna A, Capodanno D, Cera M, et al. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial). Am J Cardiol. 2009;103:1551-1555.10.1016/j.amjcard.2009.01.37819463514]Search in Google Scholar
[20. La Manna A, Prati F, Capodanno D, et al. Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient. J Cardiovasc Med. 2011;12:328-333.10.2459/JCM.0b013e328340642820962664]Search in Google Scholar
[21. Kubo T, Imanishi T, Kitabata H., et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging. 2008;1:475-484.10.1016/j.jcmg.2008.03.01219356470]Search in Google Scholar
[22. Templin C, Meyer M, Muller MF, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J. 2010;31:1792-1801.10.1093/eurheartj/ehq168290371520525979]Search in Google Scholar
[23. Tahara S, Bezerra HG, Sirbu V, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart. 2010;96:1574-1578.10.1136/hrt.2009.18803720736206]Search in Google Scholar
[24. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response following implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv. 2010;3:531-539.10.1016/j.jcin.2010.02.00820488410]Search in Google Scholar
[25. Katoh H, Shite J, Shinke T, et al. Delayed neontimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J. 2009;73:1033-1037.10.1253/circj.CJ-08-074619367014]Search in Google Scholar
[26. Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv. 2009;2:1240-1247.10.1016/j.jcin.2009.10.00620129551]Search in Google Scholar
[27. Kim JS, Fan C, Choi D, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol. 2011;146:341-346.10.1016/j.ijcard.2009.07.01219709765]Search in Google Scholar
[28. Barlis P, Regar E, Serruys PW, et al. An optical coherence tomography study of a biodegradable vs durable polymercoated limus-eluting stent: a LEADERS trial substudy. Eur Heart J. 2010;31:165-176.10.1093/eurheartj/ehp48019889649]Search in Google Scholar
[29. Guagliumi G, Sirbu V, Costa MS, et al. Long-term strut coverage of paclitaxel eluting stents compared to bare-metal stents implanted during primary PCI in acute myocardial infarction: HORIZONS-OCT. Circulation. 2011;123:274-281.10.1161/CIRCULATIONAHA.110.96318121220730]Search in Google Scholar
[30. Guagliumi G, Sirbu V, Bezerra HG, et al. Strut coverage and vessel wall response to zotarolimus-eluting and bare metal stents implanted in patients with ST-elevation myocardial infarction: the OCTAMI study. JACC Cardiovasc Interv. 2010;3:680-687.10.1016/j.jcin.2010.04.00520630463]Search in Google Scholar
[31. www.clinicaltrials.gov]Search in Google Scholar
[32. Tahara S, Chamié D, Baibars M, Alraies C, Costa M. Optical coherence tomography endpoints in stent clinical investigations: strut coverage. Int J Cardiovasc Imaging. 2011;27:271-287.10.1007/s10554-011-9796-3445964521394615]Search in Google Scholar
[33. www.infraredx.com]Search in Google Scholar
[34. Dixon SR, Grines CL, Munir A et al. Analysis of target lesion length before coronary artery stenting using angiography and near-infrared spectroscopy versus angiography alone. Am J Cardiol. 2012;109:60-66.10.1016/j.amjcard.2011.07.06821962996]Search in Google Scholar
[35. Goldstein JA, Maini B, Dixon SR et al. Detection of lipidcore plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011;4:429-437.10.1161/CIRCINTERVENTIONS.111.96326421972399]Search in Google Scholar
[36. Groves EM, Seto AH, Kern MJ. Invasive Testing for Coronary Artery Disease: FFR, IVUS, OCT, NIRS. Cardiol Clin. 2014;32:405-417.10.1016/j.ccl.2014.04.00525091966]Search in Google Scholar
[37. Roleder T, Kovacic JC, Ali Z et al. Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT. EuroIntervention. 2014;10:303-311.10.4244/EIJV10I3A5324769522]Search in Google Scholar
[38. Brugaletta S, Sabaté M. Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II. Circ J. 2014;78:1531-1539. 10.1253/circj.CJ-14-0496]Search in Google Scholar